Over 75,000 fans arrived at Jawaharlal Nehru Stadium for Karan Aujla’s concert, which made it India’s second-highest-attended ...

Why Are Non-Human Identities Crucial for Cybersecurity? Have you ever considered the significance of machine identities in your cybersecurity strategy? With cybersecurity becomes a more pressing ...

How Can Organizations Ensure the Trustworthiness of Their AI’s Self-Management in Security? Have you ever wondered how much trust you can place in Artificial Intelligence to safeguard its own security ...

If you are looking at National Health Investors and wondering whether the current share price lines up with its underlying value, you are not alone. The stock last closed at US$84.07, with returns of ...

The South African digital health and telemedicine market was already valued at around R15.7 billion back in 2023, according to industry research, and is projected to grow substantially through this ...

Eric Mendelson, President and CEO, stated that "we completed the year with a solid fourth quarter that generated normalized FFO per share growth of 8.9% compared to last year." He highlighted the SHOP ...

Preserving the craft of realistic portraiture by using only scissors, The has been present at Thao Cam Vien over the past 40 years to serve spring travelers and has never once celebrated Lunar New ...

National Health Investors Inc. (NHI) on Thursday reported a key measure of profitability in its fourth quarter. The results fell short of ...

Whole grilled snakehead fish is a popular southern offering, symbolizing resilience and prosperity in business.

New MCP audit capability brings real-time visibility into AI agent prompts, MCP tool activity, and intent classificationBOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Entro Security, the enterprise ...

The Department of Health has indicated that preparatory work has been ongoing such as the improvement of health services before any sections of the NHI Act are ready for commencement. The undertaking ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Japan by Chugai ...